Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Weller, MD
Department of Neurology, University of Zurich, Switzerland
Principal Investigator - Wolfgang Wick, MD
Department of Neurooncology, University of Heidelberg
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Heidelberg
Heidelberg, Baden-Wurttemberg, Germany
- Neurology and Radiotherapy
Tübingen, Baden-Wurttemberg, Germany
- Klinikum Aschaffenburg
Aschaffenburg, Germany
- Nervenklinik
Bamberg, Germany
- Charite
Berlin, Germany
- Neurosurgery
Düsseldorf, Germany
- Radiotherapy
Erlangen, Germany
- Neurology
Essen, Germany
- Neurosurgery
Frankfurt, Germany
- Neurosurgery
Kiel, Germany
- Neurosurgery
Mainz, Germany
- County District Hospital
Regensburg, Germany
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 1999
- Primary completion
- 28 Feb 2005
- Completion
- 31 Mar 2008
- Last update posted
- 17 Jul 2008
- Registered enrollment
- 318
- Registry id
- NCT00717210
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.